La TorreM., NigriG., FerrariL.Hospital volume hospital volume, margin status, and long-term survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.Am Surg2012; 78: 225–9.
2.
YeoC.J., CameronJ.L., SohnT.A.Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes.Ann Surg1997; 226: 248–60.
3.
VerbekeC.S., LeitchD., MenonK.V.Redefining the R1 resection in pancreatic cancer.Br J Surg2006; 93: 1232–7.
4.
RautC.P., TsengJ.F., SunC.C.Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.Ann Surg2007; 246: 52–60.
5.
AndriulliA., FestaV., BotteriE.Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies.Ann Surg Oncol2012; 19: 1644–62.
6.
MollbergN., RahbariN.N., KochM.Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis.Ann Surg2011; 254: 882–93.
7.
BoggiU., Del ChiaroM., CroceC.Prognostic implications of tumor invasion or adhesion to peripancreatic vessels in resected pancreatic cancer.Surgery2009; 146: 869–81.
8.
VerbekeC.S., MenonK.V.Redefining resection margin status in pancreatic cancer.HPB (Oxford)2009; 11: 282–9.
